Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.

Autor: Viktor von Wyl, Sara Gianella, Marek Fischer, Barbara Niederoest, Herbert Kuster, Manuel Battegay, Enos Bernasconi, Matthias Cavassini, Andri Rauch, Bernard Hirschel, Pietro Vernazza, Rainer Weber, Beda Joos, Huldrych F Günthard, Swiss HIV Cohort Study-SHCS

Publikováno v: PLoS ONE, Vol 6, Iss 11, p e27463 (2011)

BACKGROUND: Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated. METHODS: The evolution of plasma HIV-RNA (432 measurements) and cell-associated HIV-DNA (325 measurements) after cessat

Externí odkaz: https://doaj.org/article/e0d2be8073d84a5d8ebfd91ebbd937f0

Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption

Autor: Sara Gianella, Bernard Hirschel, Andri Rauch, Matthias Cavassini, Enos Bernasconi, Manuel Battegay, Barbara Niederoest, Viktor von Wyl, Beda Joos, Huldrych F. Günthard, Herbert Kuster, Swiss Hiv Cohort Study-SHCS, Marek Fischer, Pietro Vernazza, Rainer Weber

Publikováno v: PLoS ONE, Vol 6, Iss 11, p e27463 (2011)
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; et al.(2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.. PloS one, 6(11), e27463. doi: 10.1371/journal.pone.0027463. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/6c70z38x
Plos One, vol. 6, no. 11, pp. e27463
PloS one, vol 6, iss 11
Wyl, Viktor von; Gianella, Sara; Fischer, Marek; Niederoest, Barbara; Kuster, Herbert; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Rauch, Andri; Hirschel, Bernard; Vernazza, Pietro; Weber, Rainer; Joos, Beda; Günthard, Huldrych F; Swiss HIV Cohort Study-SHCS, (2011). Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption. PLoS ONE, 6(11), e27463. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027463
PLoS ONE
PloS one

Background: Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated. Methods: The evolution of plasma HIV-RNA (432 measurements) and cell-associated HIV-DNA (325 measurements) after cessat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da62b16c7419400284b6afd71a539269
http://europepmc.org/articles/PMC3216952?pdf=render

Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat.

Autor: Papadopoulos, Catherine M., Tsai, Shih-Yen, Alsbiei, Talal, O'Brien, Timothy E., Schwab, Martin E., Kartje, Gwendolyn L.

Publikováno v: Annals of Neurology; 2002, Vol. 51 Issue 4, p433-441, 9p